Literature DB >> 2879971

Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients.

F Brun-Vezinet, M A Rey, C Katlama, P M Girard, D Roulot, P Yeni, L Lenoble, F Clavel, M Alizon, S Gadelle.   

Abstract

Lymphadenopathy-associated virus type 2 (HIV 2) was isolated from 3 patients with AIDS and 1 with AIDS-related complex. Clinical features were similar to those in patients infected with HIV 1. Viral isolates were characterised by hybridisation with HIV 1 and HIV 2 DNA probes. HIV 1 and HIV 2 serological studies were performed by enzyme-linked immunosorbent assay (ELISA), western blot, and radioimmunoprecipitation assay. HIV 2 IgG antibodies were detected in all sera. The molecular weights of the most representative HIV 2 proteins were determined by immunoblot. Cross-reactivity was restricted to HIV 1 and HIV 2 core proteins. In all 4 patients the neurotropism of HIV 2 was demonstrated by virus isolation from the cerebrospinal fluid and/or by evidence of intrathecal HIV 2 IgG synthesis. All sera were antibody negative by HIV 1 ELISA. An assay specific for HIV 2 is needed for screening of blood donations and for diagnosis and seroepidemiological study of HIV 2 infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2879971     DOI: 10.1016/s0140-6736(87)91967-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

1.  HIV-2 antibody testing of blood donors with doubtful immunoblot results for HIV-1.

Authors:  J Knüver-Hopf; H Mohr; J Beyer; B Lambrecht; D Mix; H Rübsamen-Waigmann; H Schmitt
Journal:  Blut       Date:  1989-03

2.  Generation and characterization of the human immunodeficiency virus type 1 mutants.

Authors:  A Adachi; N Ono; H Sakai; K Ogawa; R Shibata; T Kiyomasu; H Masuike; S Ueda
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Possible role of the V3 domain of gp120 in resistance to an amphotericin B derivative (MS8209) blocking human immunodeficiency virus entry.

Authors:  O Pleskoff; N Sol; H Marrakchi; M Serlin; M Seman; M Alizon
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity.

Authors:  A Brelot; N Heveker; O Pleskoff; N Sol; M Alizon
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  HIV 1 and HIV 2 prevalence of seropositivity in a population of West Africa.

Authors:  N Zanchetta; P Viganò; G B Priuli; M P Ferrario; M Zago; A Pagano
Journal:  Eur J Epidemiol       Date:  1990-03       Impact factor: 8.082

6.  Production and characterization of monoclonal antibodies specific for the transmembrane protein of simian immunodeficiency virus from the African green monkey.

Authors:  T Kodama; Y Ohta; T Masuda; K Ishikawa; H Tsujimoto; M Isahakia; M Hayami
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate.

Authors:  H Kühnel; H von Briesen; U Dietrich; M Adamski; D Mix; L Biesert; R Kreutz; A Immelmann; K Henco; C Meichsner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  HIV-II infection with initial neurological manifestation.

Authors:  E Klemm; K E Schneweis; R Horn; W Tackmann; G Schulze; J Schneider
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

9.  Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers.

Authors:  M A Rey; A G Laurent; J McClure; B Krust; L Montagnier; A G Hovanessian
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

10.  Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia.

Authors:  T S Tochikura; H Nakashima; Y Ohashi; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.